{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:21:34Z","timestamp":1759339294069,"version":"3.37.3"},"reference-count":39,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"unspecified","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Catalan Health Department","award":["SLT002\/16\/00200"],"award-info":[{"award-number":["SLT002\/16\/00200"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess the impact of prehospital factors (diagnostic pathways, first presentation to healthcare services, intervals, participation in primary care) on 1-year and 5-year survival in people with epithelial ovarian cancer (EOC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Retrospective quasi-population-based cohort study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Catalan Integrated Public Healthcare System.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>People with EOC who underwent surgery with a curative intent in public Catalan hospitals between 1 January 2013 and 31 December 2014.<\/jats:p><\/jats:sec><jats:sec><jats:title>Outcome measures<\/jats:title><jats:p>Data from primary and secondary care clinical histories and care processes in the 18 months leading up to confirmation (signs and symptoms at presentation, diagnosis pathways, referrals, diagnosis interval) of the EOC diagnosis (stage, histology type, treatment). Diagnostic process intervals were based on the Aarhus statement. 1-year and 5-year survival analysis was undertaken.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 513 patients included in the cohort, 67.2% initially consulted their family physician, while 36.4% were diagnosed through emergency services. In the Cox models, survival was influenced by advanced stage at 1\u2009year (HR 3.84, 95% CI 1.23 to 12.02) and 5\u2009years (HR 5.36, 95%\u2009CI 3.07 to 9.36), as was the type of treatment received, although this association was attenuated over follow-up. Age became significant at 5\u2009years of follow-up. After adjusting for age, adjusted morbidity groups, stage at diagnosis and treatment, 5-year survival was better in patients presenting with gynaecological bleeding (HR 0.35, 95%\u2009CI 0.16 to 0.79). Survival was not associated with a starting point involving primary care (HR 1.39, 95%\u2009CI 0.93 to 2.09), diagnostic pathways involving referral to elective gynaecological care from non-general practitioners (HR 0.80, 95%\u2009CI 0.51 to 1.26), or self-presentation to emergency services (HR 0.82, 95%\u2009CI 0.52 to 1.31).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Survival in EOC is not associated with diagnostic pathways or prehospital healthcare, but it is influenced by stage at diagnosis, administration of primary cytoreduction plus chemotherapy and patient age.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2021-060499","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T15:30:20Z","timestamp":1658503820000},"page":"e060499","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Prehospital care for ovarian cancer in Catalonia: could we do better in primary care? Retrospective cohort study"],"prefix":"10.1136","volume":"12","author":[{"given":"Carmen","family":"Vela-Vallesp\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Manchon\u2010Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Aliste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep M","family":"Borras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-3090","authenticated-orcid":false,"given":"Merc\u00e8","family":"Marzo-Castillejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"2022072208301056000_12.7.e060499.1","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJCA.2018.07.005"},{"key":"2022072208301056000_12.7.e060499.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.07.022"},{"key":"2022072208301056000_12.7.e060499.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62231-3"},{"key":"2022072208301056000_12.7.e060499.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33326-3"},{"key":"2022072208301056000_12.7.e060499.5","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","article-title":"Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study","volume":"20","author":"Arnold","year":"2019","journal-title":"Lancet Oncol"},{"key":"2022072208301056000_12.7.e060499.6","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp11X588484"},{"key":"2022072208301056000_12.7.e060499.7","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21456"},{"key":"2022072208301056000_12.7.e060499.8","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.408"},{"key":"2022072208301056000_12.7.e060499.9","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.569"},{"key":"2022072208301056000_12.7.e060499.10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.canep.2018.07.010","article-title":"Which indicators of early cancer diagnosis from population-based data sources are associated with short-term mortality and survival?","volume":"56","author":"Muller","year":"2018","journal-title":"Cancer Epidemiol"},{"key":"2022072208301056000_12.7.e060499.11","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.155"},{"key":"2022072208301056000_12.7.e060499.12","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp11X572283"},{"key":"2022072208301056000_12.7.e060499.13","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.68"},{"key":"2022072208301056000_12.7.e060499.14","unstructured":"Bray F , Znaor A , Cueva P . Planning and developing population-based cancer registration in low- and middle-income settings. Lyon: IARC Technical Publication No. 43, 2015."},{"key":"2022072208301056000_12.7.e060499.15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.aprim.2016.06.003","article-title":"Los grupos de morbilidad ajustados: nuevo agrupador de morbilidad poblacional de utilidad en El \u00e1mbito de la atenci\u00f3n primaria","volume":"48","author":"Monterde","year":"2016","journal-title":"Atenci\u00f3n Primaria"},{"key":"2022072208301056000_12.7.e060499.16","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22371"},{"key":"2022072208301056000_12.7.e060499.17","unstructured":"National Institute for Health and Care Excellence . Ovarian cancer: detection in primary care; 2021. http:\/\/pathways.nice.org.uk\/pathways\/ovarian-cancer [Accessed 03 Mar 2021]."},{"key":"2022072208301056000_12.7.e060499.18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"2022072208301056000_12.7.e060499.19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ygyno.2020.05.002","article-title":"Ovarian cancer symptoms, routes to diagnosis and survival - population cohort study in the 'no screen' arm of the UK collaborative trial of ovarian Cancer screening (UKCTOCS)","volume":"158","author":"Dilley","year":"2020","journal-title":"Gynecol Oncol"},{"key":"2022072208301056000_12.7.e060499.20","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000001074"},{"key":"2022072208301056000_12.7.e060499.21","doi-asserted-by":"crossref","DOI":"10.1111\/ecc.13234","article-title":"Cancer diagnosis in Scottish primary care: results from the national cancer diagnosis audit","volume":"29","author":"Murchie","year":"2020","journal-title":"Eur J Cancer Care"},{"key":"2022072208301056000_12.7.e060499.22","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/bjc.2014.634","article-title":"Impact of investigations in general practice on timeliness of referral for patients subsequently diagnosed with cancer: analysis of national primary care audit data","volume":"112","author":"Rubin","year":"2015","journal-title":"Br J Cancer"},{"key":"2022072208301056000_12.7.e060499.23","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.71"},{"key":"2022072208301056000_12.7.e060499.24","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000562"},{"key":"2022072208301056000_12.7.e060499.25","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-6211-2","article-title":"Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines","volume":"19","author":"Funston","year":"2019","journal-title":"BMC Cancer"},{"key":"2022072208301056000_12.7.e060499.26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.amepre.2015.09.023","article-title":"A systematic review of symptoms for the diagnosis of ovarian cancer","volume":"50","author":"Ebell","year":"2016","journal-title":"Am J Prev Med"},{"key":"2022072208301056000_12.7.e060499.27","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/sj.bjc.6605382","article-title":"The national awareness and early diagnosis initiative in England: assembling the evidence","volume":"101 Suppl 2","author":"Richards","year":"2009","journal-title":"Br J Cancer"},{"key":"2022072208301056000_12.7.e060499.28","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.48"},{"key":"2022072208301056000_12.7.e060499.29","doi-asserted-by":"crossref","DOI":"10.1111\/ecc.13100","article-title":"Advanced-stage cancer and time to diagnosis: an international cancer benchmarking partnership (ICBP) cross-sectional study","volume":"28","author":"T\u00f8rring","year":"2019","journal-title":"Eur J Cancer Care"},{"key":"2022072208301056000_12.7.e060499.30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7330.148"},{"key":"2022072208301056000_12.7.e060499.31","first-page":"212","article-title":"Stage, survival and delays in lung, colorectal, prostate and ovarian cancer: comparison between diagnostic routes","volume":"57","author":"Neal","year":"2007","journal-title":"Br J Gen Pract"},{"key":"2022072208301056000_12.7.e060499.32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.2164"},{"key":"2022072208301056000_12.7.e060499.33","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-0077-3"},{"key":"2022072208301056000_12.7.e060499.34","unstructured":"Pla Director d\u2019oncologia . Generalitat de Catalunya Departament de Salut. Infographics, ovary cancer and appendages. Available: https:\/\/canalsalut.gencat.cat\/ca\/salut-a-z\/c\/cancer\/recursos-per-a-professionals\/estadistiques\/sobre-el-cancer\/ [Accessed 09 Mar 2021]."},{"key":"2022072208301056000_12.7.e060499.35","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"2022072208301056000_12.7.e060499.36","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S225568"},{"key":"2022072208301056000_12.7.e060499.37","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S206770"},{"key":"2022072208301056000_12.7.e060499.38","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-018-3476-0","article-title":"The Aarhus statement on cancer diagnostic research: turning recommendations into new survey instruments","volume":"18","author":"Coxon","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"2022072208301056000_12.7.e060499.39","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-060499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T15:30:35Z","timestamp":1658503835000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-060499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,22]]},"published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.1136\/bmjopen-2021-060499"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-060499","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}